Sun.Nov 03, 2024

article thumbnail

3 Types of Startups that Healthcare Leaders Want to See More Of

MedCity News

During HLTH, I spoke with some investors and digital health executives about the types of startups that they haven’t encountered yet — but would like to. The post 3 Types of Startups that Healthcare Leaders Want to See More Of appeared first on MedCity News.

article thumbnail

Novo Nordisk will file semaglutide for MASH next year

pharmaphorum

ESSENCE trial of Novo Nordisk's GLP-1 drug semaglutide shows efficacy in MASH, setting up filings in the US and Europe next year

107
107
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

PBGH CEO: Transparency is “Table Stakes” and an “Expectation”

MedCity News

In a recent interview, Elizabeth Mitchell, president and CEO of the Purchaser Business Group on Health, discussed employers’ challenges in accessing medical data, emphasizing the need for transparency and potential strategies to enhance their fiduciary responsibilities. The post PBGH CEO: Transparency is “Table Stakes” and an “Expectation” appeared first on MedCity News.

Medical 103
article thumbnail

Best Practices, Strategies & Use of Novel Biological Responses for Robust Cell-Based Potency Assays

PharmaTech

Cell-based assays (CBAs) are key tools for evaluating the potency of new biologic drugs. Catalent’s transcription-based bioassay simplifies and empowers the testing of new biologics.

52
article thumbnail

AI Strategies for Sales Managers: How to Cut Down on Tedious Admin Work

What if you could help your sellers stop wasting 72% of their day on non-selling activities and focus on bringing in revenue? Incorporating AI in your enablement workflows can help you cut down on busy work, get projects done faster, and let your team (and you!) focus on making a bigger impact. We put together this guide to show you how to use AI to cut time and costs for projects, including collateral creation, development of training videos, and automating tedious processes.

article thumbnail

Protein-Design Startup Archon Adds $20M to Show How ‘Cages’ Can Change Antibody Drugs

MedCity News

Archon Biosciences’ antibody cages change the structure of an antibody to control how a drug distributes in the body. The startup comes from the lab of David Baker, the University of Washington professor of biochemistry recently awarded the Nobel Prize in Chemistry for his work in computational protein design. The post Protein-Design Startup Archon Adds $20M to Show How ‘Cages’ Can Change Antibody Drugs appeared first on MedCity News.

article thumbnail

Weathering the Storms

PharmaTech

Recent hurricanes in the US close Baxter plant, shining a spotlight on supply chain fragility again.

52

More Trending

article thumbnail

FLASCO Fall Session: Advancements in MRD Monitoring Using ctDNA in Lung Cancer

Pharmacy Times

Two clinical trials with MRD monitoring may be practice changing: TRACERx and AEGEAN.

55
article thumbnail

Redefining Clinical Development of Obesity Drugs: What Does Success Look Like? 

MedCity News

As multi-billion investment continues to pour into the R&D of future obesity medications, the need for evidence generation of health benefits beyond short-term weight loss will be critical to the decision-making of healthcare providers and payers. The post Redefining Clinical Development of Obesity Drugs: What Does Success Look Like? appeared first on MedCity News.